Makes no sense why does PF say we will have partnership deal and be worth billions come early 2016 after cohort 3?? If we have to find a patient taking 2/3 months after we dose one and review then we wont be at cohort 3 til 2018.
Something doesnt make sense here. Im sure they have patients approved ready to go they have to. Someone ask this straight out because it is the most important question.
Ann: GUIDANCE ON CLINICAL TRIAL UPDATES, page-24
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)